By Marcus Devlin
Two decades covering equity markets. Writes on single stocks, sectors, valuations and the trades behind the tape.
Siemens Healthineers faces 2027 earnings squeeze, Bernstein warns
Siemens Healthineers' guidance upgrade is mostly a one-off US tariff refund, Bernstein says. The bank sees a 2027 earnings squeeze from high
Singapore shares slip 0.6% even as June retail sales rise 4%
Singapore's benchmark index slipped again, even as retail sales climbed 4% in June. Meanwhile, UOB agreed to sell its asset management arm t
UK EV Sales Hit Record 27.5% Share, But Discounts May Not Last
UK battery EVs took a record 27.5% of new-car registrations in July, but the industry warns that growth is being driven by deep discounts th
S4 Capital lifts profit margin target after cost cuts, trims revenue outlook
S4 Capital raised its full-year profit margin target after aggressive cost cuts lifted first-half profit and reduced debt. The digital ad gr
Meiji's profit jumps 51% as candy sales stay strong
Meiji Holdings' fiscal first-quarter profit jumped 51% to 15.3 billion yen, helped by steady candy sales. The company kept its dividend unch
Shanghai stocks climb 1.5% as oil slides on Hormuz talks progress
The Shanghai Composite gained 1.5% as Brent crude slid to about $79 a barrel on hopes that mediators are making headway in US-Iran talks. Lo
Novo Nordisk defends strategy after two trial setbacks
Novo Nordisk is reassuring investors after two clinical trial setbacks, saying it will stick with its strategy and pursue small 'bolt-on' de
Kikkoman's strong quarter leaves full-year forecast unchanged
Kikkoman reported a strong fiscal first quarter, with profit up 24% and revenue up 15%. Yet management kept its full-year forecast and 25 ye
Legal & General's profit beat bolsters CEO's revamp plan
Legal & General's first-half core operating profit rose 7% to £918 million, beating forecasts. The growth, led by its £1.2 trillion asset-ma
Al Jouf's Q2 profit holds steady despite weather and import pressure
Al Jouf Agricultural Development kept Q2 profit steady at SAR 9.479 million on sales of SAR 155.585 million, even as imported competition an
Sandoz beats forecasts as biosimilar sales jump 22%
Sandoz's second-quarter net sales rose 9% to $3.01 billion, beating expectations. Biosimilar revenue jumped 22% as more drug patents expire,
BlackRock takes 3% stake in Spain's Indra, worth about €316M
BlackRock revealed a 3.002% holding in Spain's Indra, valued at roughly €316 million. The move puts the defense and tech firm on the radar o